Whitehawk Therapeutics (WHWK) Finished Goods (2024)
Whitehawk Therapeutics' (WHWK) quarterly Finished Goods came in at $1.8 million in Q4 2024.
Whitehawk Therapeutics (WHWK) Finished Goods (2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 1 years of Finished Goods data on file, last reported at $1.8 million in Q4 2024.
- On a quarterly basis, Finished Goods changed N/A year-over-year to $1.8 million in Q4 2024; TTM through Dec 2024 was $1.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.8 million, changed N/A from the prior year.
- Finished Goods for Q4 2024 stood at $1.8 million.
- Over the last five years, Finished Goods for WHWK reached as high as $1.8 million in Q4 2024 and fell as low as $1.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 260.33 Mn | 49.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.78 Mn |